Omeros (OMER) Invested Capital (2011 - 2025)
Omeros (OMER) posted Invested Capital of $1.2 million for Q4 2025, down 95.45% sequentially from $26.9 million in Q1 2025, and down 37.94% YoY from $2.0 million in Q4 2024.
Omeros (OMER) Invested Capital (2011 - 2025) Analysis & Trends
Omeros has reported Invested Capital for 12 years, with the latest figure at $1.2 million in Q4 2025.
- Quarterly Invested Capital fell 37.94% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 95.76% YoY) and the FY2025 annual result came in at $1.2 million, down 37.94% from the prior year.
- Invested Capital declined to $1.2 million in Q4 2025 per OMER's latest filing, from $26.9 million in the prior quarter.
- Over five years, Invested Capital peaked at $94.9 million in Q3 2023 and troughed at $1.2 million in Q4 2025.
- A 4-year average of $51.2 million and a median of $60.7 million in 2022 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2023 and 2024: Invested Capital sank 98.63% in 2023, then jumped 53.14% in 2024.
- Over 4 years, Invested Capital stood at $94.4 million in 2022, then tumbled by 98.63% to $1.3 million in 2023, then surged by 53.14% to $2.0 million in 2024, then slumped by 37.94% to $1.2 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $1.2 million, $26.9 million, and $2.0 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 26.93 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 94.91 Mn |
| Jun 30, 2023 | 94.73 Mn |
| Mar 31, 2023 | 94.55 Mn |
| Dec 31, 2022 | 94.38 Mn |
| Dec 31, 2019 | 2.77 Mn |
| Mar 31, 2019 | 2.56 Mn |
| Dec 31, 2018 | 889,000.00 |
| Sep 30, 2018 | 560,000.00 |
| Jun 30, 2018 | 608,000.00 |
| Mar 31, 2018 | 513,000.00 |
| Dec 31, 2017 | 490,000.00 |
| Sep 30, 2017 | 368,000.00 |
| Jun 30, 2017 | 250,000.00 |
| Mar 31, 2017 | 228,000.00 |
| Dec 31, 2016 | 198,000.00 |
| Sep 30, 2016 | 190,000.00 |